Ricardo Alonso

Ricardo Alonso

Auto-generated profile, based on publicly available information

Ricardo Alonso

Hospital J.M. Ramos Mejía, Centro Universitario de Esclerosis Múltiple Buenos Aires, Argentina

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
RARicardo Alonso
Ricardo Alonso
DGDolores Gonzalez-Moron
Dolores Gonzalez-Moron
OGOrlando Garcea
Orlando Garcea

1 July 2019 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
JRJuan Rojas
Juan Rojas
ACAdriana Carrá
Adriana Carrá
JCJorge Correale
Jorge Correale
ECEdgardo Cristiano
Edgardo Cristiano
NLNora Fernández Liguori
Nora Fernández Liguori
LPLiliana Patrucco
Liliana Patrucco

15 May 2020 in International Journal of MS Care
Verified
Journal Article
Closed access
RARicardo N. Alonso
Ricardo N. Alonso
MEMaria B. Eizaguirre
Maria B. Eizaguirre
LCLeila Cohen
Leila Cohen
CQCecilia Quarracino
Cecilia Quarracino
BSBerenice Silva
Berenice Silva
OGOrlando Garcea
Orlando Garcea
Background: Scales to assess disability in multiple sclerosis (MS) rarely provide reliable data on actual global impairment. Upper limb dysfunction is usually overlooked, which has a negative effect on patient well-being. We sought to analyze associations among upper limb dexterity, lower limb speed, and Expanded Disability Status Scale (EDSS) score; the difference in upper limb dexterity between patients with EDSS scores less than 5 and 5 or greater; and the associations that upper limb dexterity, lower limb speed, and EDSS score have with health-related quality of life measurements and depression. Methods: A total of 140 adults with MS were evaluated using the Nine-Hole Peg Test, Timed 25-Foot Walk test, EDSS, Multiple Sclerosis International Quality of Life (MusiQoL) questionnaire, and Beck Depression Inventory. Thorough descriptive-analytical research was conducted using the Spearman correlation, multiple linear regression, and structural equation modeling. Results: Upper limb dexterity was more closely related to EDSS score than lower limb speed (r = 0.43 vs 0.29, R2 = 0.38) and was greatest in patients with EDSS scores less than 5 (P < .01). Moreover, upper limb dexterity was negatively associated with EDSS score and the MusiQoL questionnaire (rS = −0.557 to −0.321, P < .05). The correlation that depression has with upper limb dexterity loss was higher than the one it has with lower limb speed (0.098 vs 0.066, t > 1.96). Conclusions: Upper limb dexterity is associated with global disability, depression, and health-related quality of life. We advocate for the assessment of upper limb dexterity in patients with MS to adopt a better approach to their functional impairment.

1 August 2019 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
ECEdgar Carnero Contentti
Edgar Carnero Contentti
JPJuan Pablo Pettinicchi
Juan Pablo Pettinicchi
PLPablo A. López
Pablo A. López
RARicardo Alonso
Ricardo Alonso
OGOrlando Garcea
Orlando Garcea
VTVerónica Tkachuk
Verónica Tkachuk

1 December 2022 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
ECEdgar Carnero Contentti
Edgar Carnero Contentti
PLPablo A López
Pablo A López
JCJuan Criniti
Juan Criniti
RARicardo Alonso
Ricardo Alonso
BSBerenice Silva
Berenice Silva
JRJuan Ignacio Rojas
Juan Ignacio Rojas
Background: Neuromyelitis optica spectrum disorder (NMOSD) misdiagnosis (i.e. the incorrect diagnosis of patients who truly have NMOSD) remains an issue in clinical practice. We determined the frequency and factors associated with NMOSD misdiagnosis in patients evaluated in a cohort from Latin America. Methods: We retrospectively reviewed the medical records of patients with NMOSD, according to the 2015 diagnostic criteria, from referral clinics in six Latin American countries (Argentina, Chile, Paraguay, Colombia, Ecuador, and Venezuela). Diagnoses prior to NMOSD and ultimate diagnoses, demographic, clinical and paraclinical data, and treatment schemes were evaluated. Results: A total of 469 patients presented with an established diagnosis of NMOSD (73.2% seropositive) and after evaluation, we determined that 56 (12%) patients had been initially misdiagnosed with a disease other than NMOSD. The most frequent alternative diagnoses were multiple sclerosis (MS; 66.1%), clinically isolated syndrome (17.9%), and cerebrovascular disease (3.6%). NMOSD misdiagnosis was determined by MS/NMOSD specialists in 33.9% of cases. An atypical MS syndrome was found in 86% of misdiagnosed patients, 50% had NMOSD red flags in brain and/or spinal magnetic resonance imaging (MRI), and 71.5% were prescribed disease-modifying drugs. Conclusions: NMOSD misdiagnosis is relatively frequent in Latin America (12%). Misapplication and misinterpretation of clinical and neuroradiological findings are relevant factors associated with misdiagnosis.

25 July 2023 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
ECEdgar Carnero Contentti
Edgar Carnero Contentti
PLPablo A Lopez
Pablo A Lopez
VTVerónica Tkachuk
Verónica Tkachuk
CVCarlos Vrech
Carlos Vrech
MZMaría A Zarate
María A Zarate
JRJuan Ignacio Rojas
Juan Ignacio Rojas
Background: We aimed to assess the frequency of new asymptomatic lesions on brain and spinal imaging (magnetic resonance imaging (MRI)) and their association with subsequent relapses in a large cohort of neuromyelitis optica spectrum disorder (NMOSD) patients in Argentina. Methods: We retrospectively reviewed 675 MRI (225 performed during an attack and 450 during the relapse-free period (performed at least 3 months from the last attack)) of NMOSD patients who had at least 2 years of clinical and MRI follow-up since disease onset. Kaplan–Meier (KM) curves were used for depicting time from remission MRI to subsequent relapse. Results: We included 135 NMOSD patients (64.4% were aquaporin-4-immunoglobulin G (AQP4-IgG)-positive). We found that 26 (19.26%) and 66 (48.88%) of patients experienced at least one new asymptomatic MRI lesion during both the relapse-free period and attacks, respectively. The most frequent asymptomatic MRI lesions were optic nerves followed by short-segment myelitis during the relapse-free period and attacks. KM curves did not show differences in the time taken to develop a new relapse. Conclusion: Our findings showed that new asymptomatic lesions are relatively frequent. However, the presence of new asymptomatic MRI lesions during the relapse-free period and at relapses was not associated with a shorter time to developing subsequent relapses.